A Day Up For Allakos Inc.

Allakos Inc. (ALLK:NASDAQ) jumped higher at $0.32, a gain of 48.1%. On Wed, Apr 02, 2025, ALLK:NASDAQ hit a New 2-Week High of $0.32. The stock appeared on our News Catalysts scanner on Wed, Apr 02, 2025 at 10:21 AM in the 'AGREEMENT' category. From Wed, Mar 19, 2025, the stock recorded 10.00% Up Days and 9.09% Green Days

The stock spiked on Fri, Jan 24, 2025 at $1.26 with a volume of 1M+.

About Allakos Inc. (ALLK:NASDAQ)

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells.